InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Nova, Tina. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 1 disclosures have been recorded. History available since 4 June 2026. The latest transaction was disclosed on 4 June 2026 (50 - Grant of options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条